《新股表现》辰林教育(01593.HK)暗盘收2.21元 高上市价0.5%
根据辉立交易,明日挂牌的辰林教育(01593.HK)暗盘平开报2.2元,最高见2.29元,收报2.21元,较上市价2.2元,高0.5%或1仙;成交411万股,涉资921万元。
江西省民办高等教育服务供应商辰林教育,计划发售2.5亿股,当中一成公开发售,超购0.73倍;国际发售轻微认购不足。每手2,000股中签率为100%。以招股下限定价(介乎2.2至3.52元),集资净额为4.78亿元,当中35%将用於建设、翻新及提升大学的设施及基建;30%将用作偿还若干部份的银行贷款;25%将用作收购民办高等学校及/或民办职业学校;10%将用作营运资金及一般企业用途。独家保荐人为第一上海融资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.